CONMED has completed its previously announced acquisition of privately-held SurgiQuest, which will become part of the CONMED Advanced Surgical business.

According to a related 8-K filing and term sheet, CONMED entered into a new credit facility to fund the acquisition. JPMorgan Chase served as administrative agent for a lender group that provided $175 million term loan and a $525 million revolving credit facility. J.P. Morgan Securities, Merrill Lynch and Wells Fargo Securities served as joint lead arrangers and joint bookrunners. Bank of America and Wells Fargo as co-syndication agents and DNB Bank, U.S. Bank and The Bank of Tokyo-Mitsubishi UFJ as co-documentation agents. ,

Utica, NY-based CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.

SurgiQuest, a privately held, venture-backed company, develops manufactures, and markets the AirSeal System (AirSeal), the first integrated access management technology for use in laparoscopic and robotic procedures.